Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.

Green AR, Reifler LM, Boyd CM, Weffald LA, Bayliss EA.

Drugs Aging. 2018 Mar;35(3):223-232. doi: 10.1007/s40266-018-0522-x.

2.
3.

Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.

Campbell NL, Perkins AJ, Bradt P, Perk S, Wielage RC, Boustani MA, Ng DB.

Pharmacotherapy. 2016 Nov;36(11):1123-1131. doi: 10.1002/phar.1843. Epub 2016 Nov 5.

4.

Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.

Weichert I, Romero-Ortuno R, Tolonen J, Soe T, Lebus C, Choudhury S, Nadarajah CV, Nanayakkara P, Orrù M, Di Somma S; Global Research on Acute Conditions Team (GREAT).

J Clin Pharm Ther. 2018 Oct;43(5):682-694. doi: 10.1111/jcpt.12694. Epub 2018 May 4.

PMID:
29729025
5.

Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.

Cross AJ, George J, Woodward MC, Ames D, Brodaty H, Wolfe R, Connors MH, Elliott RA.

J Alzheimers Dis. 2017;60(2):349-358. doi: 10.3233/JAD-170265.

PMID:
28869467
6.

Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.

Pasina L, Colzani L, Cortesi L, Tettamanti M, Zambon A, Nobili A, Mazzone A, Mazzola P, Annoni G, Bellelli G.

Drugs Aging. 2019 Jan;36(1):85-91. doi: 10.1007/s40266-018-0612-9.

PMID:
30484239
7.

Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia.

Cross AJ, George J, Woodward MC, Ames D, Brodaty H, Ilomäki J, Elliott RA.

Drugs Aging. 2016 Jan;33(1):37-44. doi: 10.1007/s40266-015-0332-3.

PMID:
26645294
8.

Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.

Tsoutsoulas C, Mulsant BH, Kumar S, Ghazala Z, Voineskos AN, Menon M, Pollock BG, Rajji TK.

J Clin Psychiatry. 2017 Nov/Dec;78(9):e1284-e1290. doi: 10.4088/JCP.17m11523.

PMID:
29188908
9.

Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.

Campbell NL, Lane KA, Gao S, Boustani MA, Unverzagt F.

Pharmacotherapy. 2018 May;38(5):511-519. doi: 10.1002/phar.2106. Epub 2018 Apr 25.

10.

Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.

Wu YH, Wang CJ, Hung CH, Chen LY, Lin MH, Wang PN, Chen LK.

Geriatr Gerontol Int. 2017 Apr;17 Suppl 1:57-64. doi: 10.1111/ggi.13032.

PMID:
28436193
11.

Anticholinergic burden is associated with recurrent and injurious falls in older individuals.

Zia A, Kamaruzzaman S, Myint PK, Tan MP.

Maturitas. 2016 Feb;84:32-7. doi: 10.1016/j.maturitas.2015.10.009. Epub 2015 Oct 23.

PMID:
26531071
12.

Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study.

De Vreese LP, Mantesso U, De Bastiani E, Marangoni A, Weger E, Gomiero T.

PLoS One. 2018 Oct 31;13(10):e0205897. doi: 10.1371/journal.pone.0205897. eCollection 2018.

13.

Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.

Niznik J, Zhao X, Jiang T, Hanlon JT, Aspinall SL, Thorpe J, Thorpe C.

Drugs Aging. 2017 Dec;34(12):925-939. doi: 10.1007/s40266-017-0502-6.

14.

Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.

Boccardi V, Baroni M, Paolacci L, Ercolani S, Longo A, Giordano M, Ruggiero C, Mecocci P.

J Nutr Health Aging. 2017;21(4):389-396. doi: 10.1007/s12603-016-0787-x.

PMID:
28346565
15.

Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.

Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, Yu O, Crane PK, Larson EB.

JAMA Intern Med. 2015 Mar;175(3):401-7. doi: 10.1001/jamainternmed.2014.7663.

16.

Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.

Pasina L, Djade CD, Lucca U, Nobili A, Tettamanti M, Franchi C, Salerno F, Corrao S, Marengoni A, Iorio A, Marcucci M, Violi F, Mannucci PM.

Drugs Aging. 2013 Feb;30(2):103-12. doi: 10.1007/s40266-012-0044-x.

PMID:
23239364
17.

Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.

Brombo G, Bianchi L, Maietti E, Malacarne F, Corsonello A, Cherubini A, Ruggiero C, Onder G, Volpato S.

Drugs Aging. 2018 Oct;35(10):917-924. doi: 10.1007/s40266-018-0584-9.

PMID:
30191516
18.

Long-term anticholinergic use and the aging brain.

Cai X, Campbell N, Khan B, Callahan C, Boustani M.

Alzheimers Dement. 2013 Jul;9(4):377-85. doi: 10.1016/j.jalz.2012.02.005. Epub 2012 Nov 22.

19.

Evaluation of anticholinergic burden of medications in older adults.

West T, Pruchnicki MC, Porter K, Emptage R.

J Am Pharm Assoc (2003). 2013 Sep-Oct;53(5):496-504. doi: 10.1331/JAPhA.2013.12138.

PMID:
24030127
20.

Use of Medications with Anticholinergic Activity and Self-Reported Injurious Falls in Older Community-Dwelling Adults.

Richardson K, Bennett K, Maidment ID, Fox C, Smithard D, Kenny RA.

J Am Geriatr Soc. 2015 Aug;63(8):1561-9. doi: 10.1111/jgs.13543. Epub 2015 Jul 22.

PMID:
26200894

Supplemental Content

Support Center